Medical Devices. Driving Growth With Transformational Technology

Size: px
Start display at page:

Download "Medical Devices. Driving Growth With Transformational Technology"

Transcription

1 Medical Devices Driving Growth With Transformational Technology

2 Forward-Looking Statement Some statements in this presentation may be forward-looking statements for purposes of the Private Securities Litigation Reform Act of Abbott cautions that these forwardlooking statements are subject to risks and uncertainties that may cause actual results to differ materially from those indicated in the forward-looking statements. Economic, competitive, governmental, technological and other factors that may affect Abbott s operations are discussed in Item 1A, Risk Factors, to our Annual Report on Securities and Exchange Commission Form 10-K for the year ended Dec. 31, 2013, and are incorporated by reference. Abbott undertakes no obligation to release publicly any revisions to forward-looking statements as a result of subsequent events or developments, except as required by law. 2 Page 2

3 Balanced and Diverse Medical Device Business Abbott Medical Devices: $5.5Bn Vascular: $3.01Bn Coronary portfolio (DES/BVS) Structural heart Endovascular Diabetes: $1.3B Diabetes: $1.31Bn Blood glucose meters Blood glucose strips Medical Optics: $1.1B Vision Care: $1.14Bn Cataract >65% of Vision Care sales Refractive Corneal solutions 3 Page 3

4 Large Market Aligned with Healthcare Trends Emerging Market Investments in Healthcare Aging Population Incidence of Chronic Diseases Need for Value-Creating Healthcare Solutions $30 Billion Medical Device Market 4 Page 4

5 Leadership Positions Across Medical Devices Vascular #1 Coronary Stents #1 Bioresorbable Vascular Scaffold (BVS) #1 Mitral Valve Repair Device Diabetes #2 in U.S. retail New Flash Glucose Monitoring technology in development Vision Care #1 LASIK #2 Cataract 5 Page 5

6 Innovation Driving Profitable Growth Vascular Diabetes Care Vision Care Near-term Xience Xpedition DES FreeStyle InsuLinx Tecnis Mono/Multifocal Absorb BVS FreeStyle Precision Neo Tecnis Toric; Optiblue MitraClip FreeStyle Precision Pro Pre-loaded delivery system Supera Peripheral Stent OptiMedica Catalys laser cataract system Mid-term Absorb BVS - Japan, U.S., and China Flash Glucose Monitoring technology Refresh refractive portfolio with idesign 6 Page 6

7 Growing Presence in Emerging Markets 24% Vascular Growing to low 30s as % of sales 17% Diabetes Growing to low 20s as % of sales 20% Vision Care Growing to mid 20s as % of sales 7 Page 7

8 Vascular Growth Strategies New Technology Expansion and Emerging Market Growth Coronary Continue to expand Absorb and Xpedition usage Structural Heart Drive adoption of MitraClip Endovascular Supera Peripheral Stent System Expand globally into new markets 8 Page 8

9 Absorb: the 4th Revolution Today 1977 Balloon Angioplasty (PTCA) Bare Metal Stents (BMS) Coronary Drug Eluting Stents (DES) Absorb Bioresorbable Vascular Scaffold (BVS) After implant. After resorption. 9 Page 9

10 Absorb: Expanding Global BVS Leadership Near-Term Growth Opportunity Available in more than 60 countries worldwide Supported by a robust clinical trial program More than 5,000 patients enrolled in company-sponsored trials Completed enrollment in Absorb randomized controlled trials in U.S., Japan, and China Combined, these markets account for more than 50 percent of the global heart stent market 10 Page 10

11 Mitral Valve Disease Large Patient Population; Significant Need Prevalence of Valvular Heart Disease by Age 14 Prevalence (%) of Moderate to Severe Valve Disease All valve disease Mitral valve disease Aortic valve disease 0 Age (Years) < >75 11 Page 11

12 Structural Heart Growth Opportunity MitraClip Near-Term Growth Opportunity Addresses significant need in a large, underserved market with a firstin-class technology Continuing to progress in Europe Driving referrals into existing programs; expanding footprint to new centers Launched in U.S. in 4Q13 Improved reimbursement coverage driving further product adoptions 12 Page 12

13 Endovascular: New Opportunity in SFA Acquisition of IDEV Provides Near-Term Growth Opportunity Expands Abbott s peripheral technology portfolio Supera peripheral stent approved by FDA in March 2014 for use in SFA blockages Unique, self-expanding, interwoven wire technology SFA is one of the largest and fastest growing segment of the peripheral stent market ~$500MM market growing ~6-7 percent annually 13 Page 13

14 Diabetes Care Growth Strategies New Technology Expansion and Emerging Market Growth Accelerate growth in key emerging markets Brazil, India, China, Saudi Arabia Capture profitable share in developed markets Shifted focus to insulin-using segment Drive growth through FreeStyle InsuLinx, Precision Neo Transform market Launch next-gen Flash Glucose Monitoring technology On track for 2H14 CE Mark 14 Page 14

15 Vision Care: Cataract Market Growth Global Cataract Market: ~$5Bn Growing 5-6% Annually 80% Incidence of Cataracts With Age 1500 Adults 60+ Globally 70% 60% 50% 40% 30% 20% Millions of People % 0% Page 15

16 Vision Care Growth Strategies New Technology Expansion and Emerging Market Growth Drive above-market growth in cataract with new technologies Tecnis Optiblue Tecnis Toric Preloaded IOL delivery system OptiMedica laser cataract system Accelerate growth in key emerging markets Brazil, India, China Stimulate growth in LASIK business Diagnostic system to deliver superior visual outcomes More space between bullets. 16 Page 16

17 New Opportunity in Laser Cataract Market Acquisition of OptiMedica Provides Near-Term Growth Opportunity Further enhances Abbott s position in cataract market Provides immediate entry point into laser cataract surgery market Laser cataract surgery used in conjunction with premium lenses More space between bullets. 17 Page 17

18 Abbott Medical Devices Aligned with Abbott s Investment Identity Balanced Portfolio Leadership Innovation Emerging Markets Margin Expansion Vascular Diabetes Vision Care #1 DES #1 BVS #1 LASIK #2 Cataract #2 U.S. BGM (retail) Xience Xpedition Absorb MitraClip Supera SFA stent Optiblue; Toric Laser cataract Flash Glucose Monitoring technology 24% of Vascular 17% of ADC 20% of AMO Capturing growth in key markets Opportunities to expand in mid- to longterm with new technology 18 Page 18

19

Abbott Diagnostics. Durable Growth Business

Abbott Diagnostics. Durable Growth Business Abbott Diagnostics Durable Growth Business Forward-Looking Statement Some statements in this presentation may be forward-looking statements for purposes of the Private Securities Litigation Reform Act

More information

SAMPLE. Asia-Pacific Interventional Cardiology Procedures Outlook to 2020. Reference Code: GDMECR0061PDB. Publication Date: May 2014

SAMPLE. Asia-Pacific Interventional Cardiology Procedures Outlook to 2020. Reference Code: GDMECR0061PDB. Publication Date: May 2014 Asia-Pacific Interventional Cardiology Procedures Outlook to 2020 Reference Code: GDMECR0061PDB Publication Date: May 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2

More information

INSIDE INFORMATION ESTABLISHMENT OF JOINT VENTURE

INSIDE INFORMATION ESTABLISHMENT OF JOINT VENTURE Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness,

More information

Abbott Nutrition. Attractive Profile and Compelling Growth Opportunities

Abbott Nutrition. Attractive Profile and Compelling Growth Opportunities Attractive Profile and Compelling Growth Opportunities Forward-Looking Statement Some statements in this presentation may be forward-looking statements for purposes of the Private Securities Litigation

More information

Home Healthcare Solutions. Brent Shafer, CEO Healthcare Home Healthcare Solutions

Home Healthcare Solutions. Brent Shafer, CEO Healthcare Home Healthcare Solutions 1 Home Healthcare Solutions Brent Shafer, CEO Healthcare Home Healthcare Solutions Home Healthcare Solutions focus Accelerating growth in: Sleep Respiratory Care Home Monitoring International expansion

More information

A LEADING GLOBAL HEALTH CARE GROUP. Frankfurt Stock Exchange (DAX30): FRE US ADR program (OTC): FSNUY wwww.fresenius.com/investors

A LEADING GLOBAL HEALTH CARE GROUP. Frankfurt Stock Exchange (DAX30): FRE US ADR program (OTC): FSNUY wwww.fresenius.com/investors A LEADING GLOBAL HEALTH CARE GROUP Frankfurt Stock Exchange (DAX30): FRE US ADR program (OTC): FSNUY wwww.fresenius.com/investors SAFE HARBOR STATEMENT This presentation contains forward-looking statements

More information

SAP The World s Leading Business Software Company. Rainer Zinow, Senior Vice President SAP Cloud, SAP SE Frankfurt am Main, September 9, 2014

SAP The World s Leading Business Software Company. Rainer Zinow, Senior Vice President SAP Cloud, SAP SE Frankfurt am Main, September 9, 2014 SAP The World s Leading Business Software Company Rainer Zinow, Senior Vice President SAP Cloud, SAP SE Frankfurt am Main, September 9, 2014 Safe Harbor Statement Any statements contained in this document

More information

Health Care Worldwide. Citi - European Credit Conference September 24, 2015 - London

Health Care Worldwide. Citi - European Credit Conference September 24, 2015 - London Health Care Worldwide Citi - European Credit Conference September 24, 2015 - London Safe Harbor Statement This presentation contains forward-looking statements that are subject to various risks and uncertainties.

More information

The New Mid-Term Plan (FY2013 FY2016)

The New Mid-Term Plan (FY2013 FY2016) The New Mid-Term Plan (FY2013 FY2016) Sustainable & Profitable Growth Terumo Corporation Executive Officer Strategy Planning Department Shouji Hatano 05.09.2013 Terumo Corporation Market Dynamics Slower

More information

CATARACT SURGICAL PACKAGES

CATARACT SURGICAL PACKAGES CATARACT SURGICAL PACKAGES LenSx Laser Cataract Surgery Featuring the ORA System OKLAHOMA CITY 608 Stanton L. Young Boulevard Oklahoma City, OK 73104 405.271.1090 www.dmei.org SURGICAL PACKAGES Advanced

More information

Unilever Q Results Graeme Pitkethly / Andrew Stephen April 14 th 2016

Unilever Q Results Graeme Pitkethly / Andrew Stephen April 14 th 2016 Unilever Q1 2016 Results Graeme Pitkethly / Andrew Stephen April 14 th 2016 SAFE HARBOUR STATEMENT This announcement may contain forward-looking statements, including forward-looking statements within

More information

Health Care Worldwide

Health Care Worldwide Health Care Worldwide Barclays European High Yield and Leveraged Finance Conference October 30, 2014 London Barclays European High Yield and Leveraged Finance Conference, October 30, 2014 Copyright Page

More information

Majestic Trial 12 Month Results

Majestic Trial 12 Month Results Majestic Trial 12 Month Results S.Müller-Hülsbeck, MD, EBIR, FCIRSE, FICA ACADEMIC HOSPITALS Flensburg of Kiel University Ev.-Luth. Diakonissenanstalt zu Flensburg Knuthstraße 1, 24939 FLENSBURG Dept.

More information

Health Care Worldwide

Health Care Worldwide Health Care Worldwide Goldman Sachs - Leveraged Finance Healthcare Conference March 4, 2014 New York Goldman Sachs Leveraged Finance Conference, Fresenius SE & Co. KGaA Copyright, March 4, 2014 Page 1

More information

Health Care Worldwide

Health Care Worldwide Health Care Worldwide Credit Suisse Global Credit Products Conference September 18, 2014 Miami Credit Suisse Global Credit Products Conference, September 18, 2014 Copyright Page 1 Safe Harbor Statement

More information

Intraocular Lens (IOL) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Intraocular Lens (IOL) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Brochure More information from http://www.researchandmarkets.com/reports/2012327/ Intraocular Lens (IOL) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Description: Intraocular

More information

BG MEDICINE. Corporate Presentation February 2013

BG MEDICINE. Corporate Presentation February 2013 BG MEDICINE Corporate Presentation February 2013 CONFIDENTIAL Oct 9, 2007 Forward-Looking Statements This presentation contains forward-looking statements regarding future events or the future financial

More information

Cataract Surgical Packages

Cataract Surgical Packages Cataract Surgical Packages Cataract surgery has evolved over the years and is one of the safest and most successful procedures performed today. There are choices to consider in how your surgery is performed

More information

Abbott Adding Value in Ireland. Investment in Ireland has been consistent and regionally spread with operations in all four provinces.

Abbott Adding Value in Ireland. Investment in Ireland has been consistent and regionally spread with operations in all four provinces. Abbott in Ireland Abbott Ireland Diabetes Care Donegal Abbott Nutrition Ltd. Sligo Abbott Ireland Diagnostics Division Sligo Abbott Ireland Nutrition Division & Abbott Ireland Manufacturing Operations

More information

A LEADING GLOBAL HEALTHCARE COMPANY

A LEADING GLOBAL HEALTHCARE COMPANY A LEADING GLOBAL HEALTHCARE COMPANY Roadshow Boston March 2, 2016 Frankfurt stock exchange (DAX30): FRE US ADR program (OTC): FSNUY www.fresenius.com/investors SAFE HARBOR STATEMENT This presentation contains

More information

Abbott to Acquire Alere, Becoming Leader in Point of Care Testing and Significantly Advancing Global Diagnostics Presence

Abbott to Acquire Alere, Becoming Leader in Point of Care Testing and Significantly Advancing Global Diagnostics Presence News Release Abbott to Acquire Alere, Becoming Leader in Point of Care Testing and Significantly Advancing Global Diagnostics Presence ABBOTT GAINS LEADERSHIP IN THE $5.5 BILLION POINT OF CARE SEGMENT,

More information

1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Global Peripheral Vascular Devices Market - Market Characterization 3.

1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Global Peripheral Vascular Devices Market - Market Characterization 3. 1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 3 Global Peripheral Vascular Devices Market - Market Characterization 3.1 Peripheral Vascular Devices Market, Revenue ($m), 2004-3.2

More information

2013 A N N UA L R E P O R T

2013 A N N UA L R E P O R T 2013 ANNUAL REPORT Abbott is a global healthcare company. Our unique mix of businesses and broadly diversified portfolio of market-leading products is aligned with long-term healthcare trends in both developed

More information

Jefferies Healthcare Conference New York June 2015

Jefferies Healthcare Conference New York June 2015 Jefferies Healthcare Conference New York June 2015 Disclosure To the extent statements contained in this presentation are not descriptions of historical facts regarding Presbia PLC and its subsidiaries

More information

The Bioresorbable Vascular Stent Dr Albert Ko

The Bioresorbable Vascular Stent Dr Albert Ko The Bioresorbable Vascular Stent Dr Albert Ko Dr Albert Ko MB BS, FRACP, FCSANZ Interventional/General Cardiologist Ascot Cardiology Symposium 2013 Treatment Goals for Coronary Artery Disease Relieve of

More information

What are your options for correcting astigmatism?

What are your options for correcting astigmatism? What are your options for correcting astigmatism? If you depend upon eyeglasses, you may have experienced the inconvenience of not being able to find your glasses when you really need them. Eyeglasses

More information

Lombard Medical Technologies Inc. (Nasdaq: EVAR) Jefferies Global Healthcare Conference New York, June 2014

Lombard Medical Technologies Inc. (Nasdaq: EVAR) Jefferies Global Healthcare Conference New York, June 2014 Lombard Medical Technologies Inc. (Nasdaq: EVAR) Jefferies Global Healthcare Conference New York, June 2014 Disclaimer This presentation contains forward-looking statements as that term is defined in the

More information

World-class company that leads Japan s healthcare industry

World-class company that leads Japan s healthcare industry World-class company that leads Japan s healthcare industry Yutaro Shintaku Director and Managing Executive Officer Strategy Planning Dept. Terumo Corporation May 12, 2010 1/12 Significant shift in business

More information

The Future of Consumer Health Care

The Future of Consumer Health Care The Future of Consumer Health Care Coming Together To Lead The Consumer Health Care Industry 2 Creating a New Business Model in Consumer Health Care 3 Serve More Consumers In More Parts of the World, More

More information

MEDICAL POLICY No. 91580-R1 DRUG-ELUTING STENTS FOR ISCHEMIC HEART DISEASE

MEDICAL POLICY No. 91580-R1 DRUG-ELUTING STENTS FOR ISCHEMIC HEART DISEASE DRUG-ELUTING STENTS FOR ISCHEMIC HEART DISEASE Effective Date: October 1, 2015 Review Dates: 10/11, 10/12, 10/13, 8/14, 8/15 Date Of Origin: October 12, 2011 Status: Current Summary of Changes Clarifications:

More information

A Leading Global Health Care Group

A Leading Global Health Care Group A Leading Global Health Care Group Commerzbank German Investment Seminar January 11/12, 2016 For detailed financial information please see our annual/quarterly reports and/or conference call materials

More information

OMNI EYE SPECIALISTS. The Intraocular Lens

OMNI EYE SPECIALISTS. The Intraocular Lens OMNI EYE SPECIALISTS Intraocular Lens Options In Cataract Surgery Or Refractive Lens Exchange Surgery Your decision to have vision surgery is important and the doctors at Omni Eye Specialists will explain

More information

EDWARDS LIFESCIENCES REPORTS STRONG FIRST QUARTER RESULTS DRIVEN BY SALES GROWTH OF 18.8 PERCENT

EDWARDS LIFESCIENCES REPORTS STRONG FIRST QUARTER RESULTS DRIVEN BY SALES GROWTH OF 18.8 PERCENT Edwards Lifesciences Corporation One Edwards Way Irvine, CA USA 92614 Phone: 949.250.2500 Fax: 949.250.2525 www.edwards.com FOR IMMEDIATE RELEASE Media Contact: Amanda C. Fowler, 949-250-5070 Investor

More information

A Leading Global Health Care Group

A Leading Global Health Care Group A Leading Global Health Care Group HSBC Healthcare Day, November 12, 2014 For detailed financial information please see our annual/quarterly reports and/or conference call materials on www.fresenius.com/ir.

More information

Welcome to our Office!

Welcome to our Office! Randy Burks, MD, FACS Raymond Gailitis, MD, FACS Northwest Medical Plaza 5800 Colonial Drive, Suite 100-103 Margate, Florida 33063 954-977-8770 Comprehensive Eye Care 954-969-0090 LASIK 954-977-8774 Fax

More information

LEADING-EDGE Cardiovascular Care

LEADING-EDGE Cardiovascular Care LEADING-Edge Cardiovascular Care Coral Gables Hospital North Shore Medical Center Hialeah Hospital Delray Medical Center Good Samaritan Medical Center Palm Beach Gardens Medical Center St. Mary s Medical

More information

Transforming Healthcare. Transforming Lives. Company Overview

Transforming Healthcare. Transforming Lives. Company Overview Transforming Healthcare. Transforming Lives. Company Overview Kobi Graham, Australia One of the more than 9 million people transformed by a Medtronic product or therapy. Innovating for life. The Medtronic

More information

THE 2009 ANNUAL AMBULATORY SURGICAL TREATMENT CENTER QUESTIONNAIRE. 24-29 Definitions

THE 2009 ANNUAL AMBULATORY SURGICAL TREATMENT CENTER QUESTIONNAIRE. 24-29 Definitions THE 2009 ANNUAL AMBULATORY SURGICAL TREATMENT CENTER QUESTIONNAIRE Page Number P1-P2 Preface 3 22 Questionnaire Form 23 Charity Care Worksheet 24-29 Definitions PREFACE TO THE 2009 ANNUAL AMBULATORY SURGICAL

More information

QT VASCULAR REPORTS 9M2015 REVENUE OF US$9.1M

QT VASCULAR REPORTS 9M2015 REVENUE OF US$9.1M MEDIA RELEASE QT VASCULAR REPORTS 9M2015 REVENUE OF US$9.1M Highlights: Gross profit margin improved to 35.4% in 9M2015, up from 12.6% in 9M2014 Working capital position will strengthen with conversion

More information

Heart Center Packages

Heart Center Packages Heart Center Packages For more information and appointments, Please contact The Heart Center of Excellence at the American Hospital Dubai Tel: +971-4-377-6571 Email: heartcenter@ahdubai.com www.ahdubai.com

More information

FY2015 Final Hospital Inpatient Rule Summary

FY2015 Final Hospital Inpatient Rule Summary FY2015 Final Hospital Inpatient Rule Summary Interventional Cardiology (IC) Peripheral Interventions (PI) Rhythm Management (RM) On August 4, 2014, the Centers for Medicare & Medicaid Services (CMS) released

More information

Premium IOL Implantation Calculations in Post-LASIK Cataract Eyes Using ASCRS IOL Calculator

Premium IOL Implantation Calculations in Post-LASIK Cataract Eyes Using ASCRS IOL Calculator Premium IOL Implantation Calculations in Post-LASIK Cataract Eyes Using ASCRS IOL Calculator Sahiba K Chailertborisuth, Saneha K. C. Borisuth, Navaneet S.C. Borisuth, MD, PhD Virdi Eye Clinic & Laser Vision

More information

A Leading Global Health Care Group

A Leading Global Health Care Group A Leading Global Health Care Group JP Morgan Milan Investor Forum October 1, 2015 For detailed financial information please see our annual/quarterly reports and/or conference call materials on www.fresenius.com/ir.

More information

Isn t it time to see what you ve been missing?

Isn t it time to see what you ve been missing? Isn t it time to see what you ve been missing? The world s most sophisticated laser cataract surgery system About cataracts and cataract surgery A cataract is a common condition in which the normally clear

More information

WHAT IS A CATARACT, AND HOW IS IT TREATED?

WHAT IS A CATARACT, AND HOW IS IT TREATED? 4089 TAMIAMI TRAIL NORTH SUITE A103 NAPLES, FL 34103 TELEPHONE (239) 262-2020 FAX (239) 435-1084 DOES THE PATIENT NEED OR WANT A TRANSLATOR, INTERPRETOR OR READER? YES NO TO THE PATIENT: You have the right,

More information

Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona

Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona Christopher M. Wright, MD, MBA Pioneer Cardiovascular Consultants Tempe, Arizona Areas to be covered Historical, current, and future treatments for various cardiovascular disease: Atherosclerosis (Coronary

More information

Private Healthcare. How To Apply For IFC Financing About IFC CREATING OPPORTUNITY IN EMERGING MARKETS

Private Healthcare. How To Apply For IFC Financing About IFC CREATING OPPORTUNITY IN EMERGING MARKETS How To Apply For IFC Financing About IFC A company or entrepreneur seeking to establish a new health project or expand an IFC, a member of the World Bank Group, is the largest global development existing

More information

Novel Targeted Immunotherapy Approach for Metastatic Melanoma Under Phase 3 Investigation

Novel Targeted Immunotherapy Approach for Metastatic Melanoma Under Phase 3 Investigation Novel Targeted Immunotherapy Approach for Metastatic Melanoma Under Phase 3 Investigation Hans S. Keirstead President, NeoStem Oncology NeoStem Presented by GTC, a conference production company 626-256-6405

More information

A Leading Global Health Care Group

A Leading Global Health Care Group A Leading Global Health Care Group Commerzbank Sector Conference September 8, 2014 For detailed financial information please see our annual/quarterly reports and/or conference call materials on www.fresenius.com/ir.

More information

An introduction to Optos

An introduction to Optos An introduction to Optos Building The Retina Company Roy Davis, CEO Christine Soden, CFO 1 Forward-Looking Statements Certain statements made in this presentation are forward-looking statements. These

More information

Visual Acuity, Impairments and Vision Insurance Plan Provisions. Stuart West Specialty Sales Manager Virginia CE Forum 2009 Course # 201718

Visual Acuity, Impairments and Vision Insurance Plan Provisions. Stuart West Specialty Sales Manager Virginia CE Forum 2009 Course # 201718 Visual Acuity, Impairments and Vision Insurance Plan Provisions Stuart West Specialty Sales Manager Virginia CE Forum 2009 Course # 201718 How Vision Works Light passes through the cornea & lens Light

More information

Welcome to the Verisyse Seminar

Welcome to the Verisyse Seminar Patient Seminar Welcome to the Verisyse Seminar Today we ll answer some of the most common questions about the Verisyse Phakic Intraocular Lens (IOL) including: Who is a candidate How the procedure is

More information

COS Statement on Values for Uninsured Services in Canada

COS Statement on Values for Uninsured Services in Canada COS Statement on Values for Uninsured Services in Canada Introduction A number of eye health services provided by physicians are not considered medically necessary and are therefore not insured under provincial

More information

I will now explain the results from the 2 nd quarter and first half of fiscal year ending March, 2014.

I will now explain the results from the 2 nd quarter and first half of fiscal year ending March, 2014. I will now explain the results from the 2 nd quarter and first half of fiscal year ending March, 2014. First, let me go over the highlights from the first half results. Due to factors including the weak

More information

Acquisition of. Special Investor Presentation

Acquisition of. Special Investor Presentation Acquisition of Special Investor Presentation October 21, 2015 Forward-looking Statements This presentation contains statements which constitute forward-looking statements within the meaning of Section

More information

Abbott 2011 Annual Report

Abbott 2011 Annual Report 2011 Annua l Re po rt i Abbott is a global, diversifi ed healthcare company devoted to the discovery, development, manufacture and marketing of pharmaceuticals, nutritional products for children and adults,

More information

2014 Procedural Reimbursement Guide Select Percutaneous Coronary Interventions

2014 Procedural Reimbursement Guide Select Percutaneous Coronary Interventions 2014 Procedural Reimbursement Guide Select Percutaneous Coronary Interventions IC-221010-AA Jan 2014 Page 1 of 10 Interventional Cardiology This for interventional cardiology procedures provides coding

More information

CHESHIRE EAST COUNCIL DRIVER MEDICAL

CHESHIRE EAST COUNCIL DRIVER MEDICAL BLOCK LETTERS PLEASE: CHESHIRE EAST COUNCIL DRIVER MEDICAL FULL NAME OF APPLICANT:.. DATE OF BIRTH.... ADDRESS:............. POST CODE... This certificate, which must be completed by a Registered Medical

More information

Emerging market opportunities for Roche. Luke Miels, Head of Asia-Pacific Roche Pharmaceuticals

Emerging market opportunities for Roche. Luke Miels, Head of Asia-Pacific Roche Pharmaceuticals Emerging market opportunities for Roche Luke Miels, Head of Asia-Pacific Roche Pharmaceuticals International region overview Eastern Europe & Middle East Asia Pacific Africa Latin America Market drivers

More information

I HAVE SUDDENLY STARTED SEEING BLURRY. WHY WOULD THAT BE?

I HAVE SUDDENLY STARTED SEEING BLURRY. WHY WOULD THAT BE? I HAVE SUDDENLY STARTED SEEING BLURRY. WHY WOULD THAT BE? THIS COULD BE DUE TO CATARACT A cataract is clouding of the lens in the eye that affects vision. Most cataracts are related to aging. A cataract

More information

Your one stop vision centre Our ophthalmic centre offers comprehensive eye management, which includes medical,

Your one stop vision centre Our ophthalmic centre offers comprehensive eye management, which includes medical, sight see OLYMPIA EYE & LASER CENTRE Your one stop vision centre Our ophthalmic centre offers comprehensive eye management, which includes medical, At the Olympia Eye & Laser Centre, our vision is to improve

More information

NC DIVISION OF SERVICES FOR THE BLIND POLICIES AND PROCEDURES VOCATIONAL REHABILITATION

NC DIVISION OF SERVICES FOR THE BLIND POLICIES AND PROCEDURES VOCATIONAL REHABILITATION NC DIVISION OF SERVICES FOR THE BLIND POLICIES AND PROCEDURES VOCATIONAL REHABILITATION Section: E Revision History Revised 01/97; 05/03; 02/08; 04/08; 03/09; 05/09; 12/09; 01/11; 12/14 An individual is

More information

Tungsten Corporation plc Results for the six months ending 31 October 2014

Tungsten Corporation plc Results for the six months ending 31 October 2014 Tungsten Corporation plc Results for the six months ending 31 October 2014 January 2015 Important information This document contains forward-looking statements that may or may not prove accurate. For example,

More information

Clinical Commissioning Policy Statement: Percutaneous mitral valve leaflet repair for mitral regurgitation April 2013. Reference: NHSCB/A09/PS/b

Clinical Commissioning Policy Statement: Percutaneous mitral valve leaflet repair for mitral regurgitation April 2013. Reference: NHSCB/A09/PS/b Clinical Commissioning Policy Statement: Percutaneous mitral valve leaflet repair for mitral regurgitation April 2013 Reference: NHS Commissioning Board Clinical Commissioning Policy Statement: Percutaneous

More information

Investor Presentation. Acquisition. LCA-Vision. February 14, 2014

Investor Presentation. Acquisition. LCA-Vision. February 14, 2014 Investor Presentation Acquisition. LCA-Vision. February 14, 2014 Safe Harbor Statement This presentation includes forward-looking statements, particularly those describing PhotoMedex' and LCA-Vision s

More information

LCA Vision Inc. November 2013. Investor Presentation

LCA Vision Inc. November 2013. Investor Presentation LCA Vision Inc. November 2013 Investor Presentation Forward Looking Statements 2 This presentation contains forward looking statements that are subject to risks and uncertainties including, but not limited

More information

The Calhoun adjustable IOL breaks new ground

The Calhoun adjustable IOL breaks new ground Page 1 of 5 Article Date: 3/1/2014 Focus on Cornea The Calhoun adjustable IOL breaks new ground Chemical technology allows the lens reshape itself to produce precise outcomes after implantation. BY JERRY

More information

Growth Through NPS & Lean Six Sigma

Growth Through NPS & Lean Six Sigma GE Healthcare Growth Through NPS & Lean Six Sigma Dee Mellor July 26, 2006 This document contains "forward-looking statements" - that is, statements related to future, not past, events. In this context,

More information

Tucson Eye Care, PC. Informed Consent for Cataract Surgery And/Or Implantation of an Intraocular Lens

Tucson Eye Care, PC. Informed Consent for Cataract Surgery And/Or Implantation of an Intraocular Lens Tucson Eye Care, PC Informed Consent for Cataract Surgery And/Or Implantation of an Intraocular Lens INTRODUCTION This information is provided so that you may make an informed decision about having eye

More information

Phone: +44 20 8123 2220 Fax: +44 207 900 3970 office@marketpublishers.com https://marketpublishers.com

Phone: +44 20 8123 2220 Fax: +44 207 900 3970 office@marketpublishers.com https://marketpublishers.com North American Home Healthcare Market, By Product [Blood Glucose Meter, ECG, IV Equipment, Nutrition, Wheelchair, Fitness, Heart Rate Monitor, Pregnancy Test Kit], Services [Respiratory Therapy, Rehabilitation

More information

Interventional Cardiology Peripheral Interventions Rhythm Management

Interventional Cardiology Peripheral Interventions Rhythm Management FY2016 Hospital Inpatient Rule (IPPS) Interventional Cardiology Peripheral Interventions Rhythm Management On April 17, 2015 the Centers for Medicare and Medicaid Services (CMS) released the Hospital Inpatient

More information

Credit Suisse Global Health Care Conference. March 5, 2013

Credit Suisse Global Health Care Conference. March 5, 2013 Credit Suisse Global Health Care Conference March 5, 2013 Safe Harbor Statement This presentation contains forward-looking statements that are subject to various risks and uncertainties. Future results

More information

First Quarter Fiscal 2010 Results Presentation

First Quarter Fiscal 2010 Results Presentation First Quarter Fiscal 2010 Results Presentation March 2, 2010 Safe Harbor Statement This announcement contains forward-looking statements. These statements are made under the safe harbor provisions of the

More information

OCT ASSESSMENT OF CUTTING BALLOON ANGIOPLASTY FOR IN-STENT RESTENOSIS

OCT ASSESSMENT OF CUTTING BALLOON ANGIOPLASTY FOR IN-STENT RESTENOSIS OCT ASSESSMENT OF CUTTING BALLOON ANGIOPLASTY FOR IN-STENT RESTENOSIS Division of Cardiology, Mount Sinai Hospital, New York, NY, USA Yuliya Vengrenyuk, PhD; and Annapoorna Kini, MD OCT ASSESSMENT OF CUTTING

More information

New Orleans Computer Club. November 2 th, 2011 Ginny Kullman, MD Department of Ophthalmology Ochsner Medical Center

New Orleans Computer Club. November 2 th, 2011 Ginny Kullman, MD Department of Ophthalmology Ochsner Medical Center New Orleans Computer Club November 2 th, 2011 Ginny Kullman, MD Department of Ophthalmology Ochsner Medical Center Background information: field of ophthalmology anatomy of the eye how the eye works Common

More information

SAP The World s Leading Business Software Company

SAP The World s Leading Business Software Company SAP The World s Leading Business Software Company Luka Mucic, Member of the Executive Board of SAP SE, CFO and COO, SAP SE Munich, September 24, 2014 Safe Harbor Statement Any statements contained in this

More information

A Leading Global Health Care Group

A Leading Global Health Care Group A Leading Global Health Care Group Credit Suisse Global Health Care Conference, March 4, 2015 For detailed financial information please see our annual/quarterly reports and/or conference call materials

More information

FY2015 Proposed Hospital Inpatient Rule Summary

FY2015 Proposed Hospital Inpatient Rule Summary FY2015 Proposed Hospital Inpatient Rule Summary Cardiac Rhythm Management (CRM) Electrophysiology (EP) Interventional Cardiology (IC) Peripheral Intervention (PI) On April 30, 2014, the Centers for Medicare

More information

AcrySof IQ Toric IOL (SN6ATT) Surgeon Keys for Success & Acknowledgement

AcrySof IQ Toric IOL (SN6ATT) Surgeon Keys for Success & Acknowledgement AcrySof IQ Toric IOL (SN6ATT) Surgeon Keys for Success & Acknowledgement Alcon Laboratories, Inc is pleased to announce the availability of the AcrySof IQ Toric intraocular lens, and delighted that you

More information

Yukon Choice DES + Translumina - The polymer-free DES solution. www.translumina.de. Coronary Stent System for Drug Application

Yukon Choice DES + Translumina - The polymer-free DES solution. www.translumina.de. Coronary Stent System for Drug Application Coronary Stent System for Drug Application Yukon Choice DES + new catheter polymer-free DES Translumina - The polymer-free DES solution www.translumina.de A First Class Stent The YUKON Choice DES+ is the

More information

OHTAC Recommendation

OHTAC Recommendation OHTAC Recommendation Multiple Sclerosis and Chronic Cerebrospinal Venous Insufficiency Presented to the Ontario Health Technology Advisory Committee in May 2010 May 2010 Issue Background A review on the

More information

Vision Glossary of Terms

Vision Glossary of Terms Vision Glossary of Terms EYE EXAMINATION PROCEDURES Eyeglass Examinations: The standard examination procedure for a patient who wants to wear eyeglasses includes at least the following: Case history; reason

More information

Cardiac Rehabilitation

Cardiac Rehabilitation Cardiac Rehabilitation Cardiac Rehabilitation Most patients return to usual activities within a few months after a heart attack and/or surgery. Cardiac rehabilitation (rehab) monitors and assists you

More information

Your Vision is Changing. It s Normal.

Your Vision is Changing. It s Normal. Your Vision is Changing. It s Normal. Cataracts. Presbyopia Changes of the Maturing Eye All of us notice an important change in our vision sometime around the age of 45. It seems like we wake up one day

More information

ADDENDUM to the Informed Consent for Cataract Surgery with Intraocular Lens Implant

ADDENDUM to the Informed Consent for Cataract Surgery with Intraocular Lens Implant ADDENDUM to the Informed Consent for Cataract Surgery with Intraocular Lens Implant INTRODUCTION Except for unusual situations, a cataract operation is indicated only when you cannot function satisfactorily

More information

VARIAN MEDICAL SYSTEMS JP Morgan Healthcare Conference -

VARIAN MEDICAL SYSTEMS JP Morgan Healthcare Conference - VARIAN MEDICAL SYSTEMS JP Morgan Healthcare Conference - Dow Wilson, CEO January 13, 2015 January 2015 2015 VARIAN MEDICAL SYSTEMS. ALL RIGHTS RESERVED. Forward-Looking Statements Forward-Looking Statements

More information

April 29, 2015 INVESTOR NEWS. Fresenius Medical Care reports first quarter 2015 results and confirms guidance for full year 2015

April 29, 2015 INVESTOR NEWS. Fresenius Medical Care reports first quarter 2015 results and confirms guidance for full year 2015 April 29, 2015 INVESTOR NEWS Fresenius Medical Care reports first quarter 2015 results and confirms guidance for full year 2015 First quarter performance fully on track to achieve full year guidance Strong

More information

The Orthodox Health Plan provides benefits for the clergy and lay employees of:

The Orthodox Health Plan provides benefits for the clergy and lay employees of: The Orthodox Health Plan provides benefits for the clergy and lay employees of: The Serbian Orthodox Church of the United States The Greek Orthodox Archdiocese of America The Antiochian Orthodox Christian

More information

Cardiac Rehab. Home. www.homecareforyou.com. Do you suffer from a cardiac condition that is limiting your independence in household mobility?

Cardiac Rehab. Home. www.homecareforyou.com. Do you suffer from a cardiac condition that is limiting your independence in household mobility? TM Nightingale Home Cardiac Rehab Do you suffer from a cardiac condition that is limiting your independence in household mobility? Such as, 1. A recent heart attack 2. A heart condition coronary artery

More information

Contrast sensitivity and vision at all distances: Intraocular lenses from ZEISS obtained excellent results in studies

Contrast sensitivity and vision at all distances: Intraocular lenses from ZEISS obtained excellent results in studies Contrast sensitivity and vision at all distances: Intraocular lenses from ZEISS obtained excellent results in studies At the summer meeting of the European Society of Cataract and Refractive Surgeons (ESCRS)

More information

Eye Department Baden-Baden. Prof. Dr. med. Frank Faude Dr. med. Susanne Faude Oxana Bräunlich. Ophthalmology specialists

Eye Department Baden-Baden. Prof. Dr. med. Frank Faude Dr. med. Susanne Faude Oxana Bräunlich. Ophthalmology specialists E y e D e p a r t m e n t Prof. Dr. med. Frank Faude Dr. med. Susanne Faude Oxana Bräunlich Ophthalmology specialists Prof. Dr. med. Frank Faude Inpatient and outpatient treatment at the Stadtklinik Baden-Baden

More information

POSITION PAPER November 2011 IMPROVING ACCESS TO MODERN CATARACT SURGERY IN EUROPE THROUGH EXPANDING PATIENT CHOICE. Page 1 of 8

POSITION PAPER November 2011 IMPROVING ACCESS TO MODERN CATARACT SURGERY IN EUROPE THROUGH EXPANDING PATIENT CHOICE. Page 1 of 8 POSITION PAPER November 2011 IMPROVING ACCESS TO MODERN CATARACT SURGERY IN EUROPE THROUGH EXPANDING PATIENT CHOICE Page 1 of 8 Contents SUMMARY... 3 DEFINITIONS... 5 MONOFOCAL INTRAOCULAR LENSES AS STANDARD

More information

StentViz Enhanced Stent Visualization

StentViz Enhanced Stent Visualization GE Healthcare StentViz Enhanced Stent Visualization Dr. Morice, Dr. Lefèvre, Dr. Hovasse, Dr. Chevalier, Dr. Louvard Institut Cardiovasculaire Paris Sud, Massy, France Assessing the deployment of stents

More information

INTRODUCTION TO ilasik

INTRODUCTION TO ilasik INTRODUCTION O TO ilasik TM It s Time For The ilasik Procedure Using a unique combination of the most advanced technology, the ilasik procedure is fast, safe and proven Nearly 290 million people worldwide

More information

The end-user applications for these systems are segmented into three categories:

The end-user applications for these systems are segmented into three categories: Brochure More information from http://www.researchandmarkets.com/reports/3339348/ Nurse Call Systems (NCS) Market Analysis: By Type (Traditional NCS, Advanced NCS, Middleware Interfaced NCS), By End Users

More information

Contents. MicroPort Scientific Completes Acquisition of Wright Medical's OrthoRecon Business

Contents. MicroPort Scientific Completes Acquisition of Wright Medical's OrthoRecon Business January 2014 MicroPort Scientific Corporation (HK: 853) Volume 28 MicroPort Scientific Completes Acquisition of Wright Medical's OrthoRecon Business SHANGHAI January 10, 2014 MicroPort Scientific Corporation

More information

ST. DAVID S MEDICAL CENTER CARDIOLOGY - Special, Invasive, Diagnostic, or High-Risk Procedure Requirements

ST. DAVID S MEDICAL CENTER CARDIOLOGY - Special, Invasive, Diagnostic, or High-Risk Procedure Requirements ST. DAVID S MEDICAL CENTER CARDIOLOGY - Special, Invasive, Diagnostic, or High-Risk Procedure Requirements Cardiac Catheterization & Peripheral Angiography Completion of a fellowship in Cardiovascular

More information

Alcon. January 2016 Page 1 of 5 Novartis AG 2016 www.novartis.com

Alcon. January 2016 Page 1 of 5 Novartis AG 2016 www.novartis.com Alcon Alcon is a global leader in eye care and offers and extensive breadth of products serving the full lifecycle of patient needs across eye diseases, vision conditions and refractive errors. In 2015,

More information

SUBMISSION ACCC Report to the Senate on Private Health Insurance

SUBMISSION ACCC Report to the Senate on Private Health Insurance SUBMISSION ACCC Report to the Senate on Private Health Insurance Medtronic Australasia welcomes the opportunity to contribute to the preparation of the Australian Competition and Consumer Commission (ACCC)

More information

This is GE Healthcare

This is GE Healthcare This is GE Healthcare An Overview Imagination at work Last updated July 2014 General Electric: A heritage of innovation Founded by Thomas Edison in 1878 Only company from the original 1896 Dow Jones index

More information